INDU Committee Report
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Appendix C: List of Witnesses
The following table lists the witnesses who appeared before the committee at its meetings related to this report. Transcripts of all public meetings related to this report are available on the committee’s webpage for this study.
Organizations and Individuals |
Date |
Meeting |
As an individual Dr. Alain Lamarre, Full Professor, Institut national de la recherche scientifique |
2022/04/08 |
17 |
BioNiagara John R. Fulton, President, Spokesperson and Representative for Biolyse Pharma Corporation |
2022/04/08 |
17 |
BIOTECanada Andrew Casey, President and Chief Executive Officer |
2022/04/08 |
17 |
BioVectra Inc. Dr. Marc Sauer, Vice-President, Process Science and Development Services Oliver Technow, Chief Executive Officer |
2022/04/08 |
17 |
Department of Industry Rodrigo Arancibia, Senior Director, Life Sciences and Biomanufacturing Branch Eric Costen, Senior Assistant Deputy Minister, Industry Sector Darryl C. Patterson, Director General, Life Sciences and Biomanufacturing Branch Daniel Quinn, Director, Research Infrastructure and Outreach, Science and Research Sector |
2022/04/08 |
17 |
National Research Council of Canada Maria Aubrey, Vice-President, Strategic Initiatives Lakshmi Krishnan, Vice-President, Life Sciences |
2022/04/08 |
17 |
Vaccine and Infectious Disease Organization - International Vaccine Centre Dr. Volker Gerdts, Director and Chief Executive Officer |
2022/04/08 |
17 |